References from Osteoprotegerin lowers type 2 diabetes risk: insights from drug-target Mendelian randomization and mediation analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
No reference evidence is available for this admitted work.
References for Osteoprotegerin lowers type 2 diabetes risk: insights from drug-target Mendelian randomization and mediation analysis | ResearchHub - ResearchHub
